Study on Bisphosphonate-Associated Osteonecrosis of the Jaw
Author Information
Author(s): Falk Wehrhan, Hyckel Peter, Guentsch Arndt, Nkenke Emeka, Stockmann Phillip, Schlegel Karl A, Neukam Friedrich W, Amann Kerstin
Primary Institution: University of Erlangen-Nuremberg, Germany
Hypothesis
The study aims to compare the expression of TGFβ1-related signaling molecules and Galectin-3 in BRONJ-affected and healthy mucosal tissues.
Conclusion
Disrupted TGFβ1 signaling was associated with delayed periodontal repair in BRONJ samples, indicating different impairments in TGFβ1-signaling compared to osteoradionecrosis.
Supporting Evidence
- TGFβ1 and Smad-2/3 were significantly decreased in BRONJ samples compared to normal tissue.
- Smad-7 was significantly increased in the BRONJ group.
- Galectin-3 staining was significantly increased in both BRONJ and osteoradionecrosis groups compared to normal tissue.
Takeaway
This study looked at how a medicine called bisphosphonate affects healing in the mouth, finding that it can slow down the repair process.
Methodology
The study involved histological analysis of oral mucosal tissue samples from patients with BRONJ, osteoradionecrosis, and healthy controls, using immunohistochemistry to assess protein expression.
Potential Biases
Potential observer bias in counting stained cells, as assessments were made by independent observers.
Limitations
The study did not include a standardized automated counting of immunohistochemically labeled cells.
Participant Demographics
The BRONJ group included 20 patients with a history of bisphosphonate treatment, while the osteoradionecrosis group included 20 patients treated with radiotherapy.
Statistical Information
P-Value
p < 0.025
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website